Bereich
Pneumologie und Schlafmedizin
PNEUMO · Dept. I
Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
Hundsberger T, Rohrbach M, Kern L, Rösler K. Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease. J Neurol 2013; 260:2279-2285.
08.06.2013Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
08.06.2013J Neurol 2013; 260:2279-2285
Hundsberger Thomas, Rohrbach Marianne, Kern Lukas, Rösler Kai M
Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis
Baty F, Rüdiger J, Miglino N, Kern L, Borger P, Brutsche M. Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis. BMC bioinformatics 2013; 14:178.
06.06.2013Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis
06.06.2013BMC bioinformatics 2013; 14:178
Baty Florent, Rüdiger Jochen, Miglino Nicola, Kern Lukas, Borger Peter, Brutsche Martin
Comorbidities and Burden of COPD: A Population Based Case-Control Study
Baty F, Putora P, Isenring B, Blum T, Brutsche M. Comorbidities and Burden of COPD: A Population Based Case-Control Study. PloS one 2013; 8:e63285.
17.05.2013Comorbidities and Burden of COPD: A Population Based Case-Control Study
17.05.2013PloS one 2013; 8:e63285
Baty Florent, Putora Paul Martin, Isenring Bruno, Blum Torsten, Brutsche Martin
Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested?
Schwitter M, Früh M, Schneider T, Kluckert J, Rodriguez R, Brutsche M. Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested?. Oncology 2013; 2013:263-268.
14.05.2013Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested?
14.05.2013Oncology 2013; 2013:263-268
Schwitter Michael, Früh Martin, Schneider Tino, Kluckert Jörg-Thomas, Rodriguez Regulo, Brutsche Martin
Epidermal growth factor receptor mutation in a patient with squamous cell carcinoma of the lung: who should be tested?
Schwitter M, Rodriguez R, Schneider T, Kluckert T, Brutsche M, Früh M. Epidermal growth factor receptor mutation in a patient with squamous cell carcinoma of the lung: who should be tested?. Case Rep Oncol 2013; 6:263-8.
14.05.2013Epidermal growth factor receptor mutation in a patient with squamous cell carcinoma of the lung: who should be tested?
14.05.2013Case Rep Oncol 2013; 6:263-8
Schwitter Michael, Rodriguez Regulo, Schneider Tino, Kluckert Thomas, Brutsche Martin, Früh Martin
Cognitive performance in high-altitude climbers: a comparative study of saccadic eye movements and neuropsychological tests
Merz T, Turk A, Hess T, Schoch O, Bloch K, Schmitt K, Hefti U, Pichler J, Barthelmes D, Bosch M, Schwarz U. Cognitive performance in high-altitude climbers: a comparative study of saccadic eye movements and neuropsychological tests. Eur J Appl Physiol 2013; 113:2025-37.
06.04.2013Cognitive performance in high-altitude climbers: a comparative study of saccadic eye movements and neuropsychological tests
06.04.2013Eur J Appl Physiol 2013; 113:2025-37
Merz Tobias M, Turk Alexander J, Hess Thomas, Schoch Otto, Bloch Konrad E, Schmitt Kai-Uwe, Hefti Urs, Pichler Jacqueline, Barthelmes Daniel, Bosch Martina M, Schwarz Urs
Tuberculosis screening in immigrants from high-prevalence countries: interview first or chest radiograph first? A pro/con debate
Mor Z, Leventhal A, Diacon A, Finger R, Schoch O. Tuberculosis screening in immigrants from high-prevalence countries: interview first or chest radiograph first? A pro/con debate. Respirology 2013; 18:432-8.
01.04.2013Tuberculosis screening in immigrants from high-prevalence countries: interview first or chest radiograph first? A pro/con debate
01.04.2013Respirology 2013; 18:432-8
Mor Zohar, Leventhal Alex, Diacon Andreas H, Finger Rebekka, Schoch Otto
Sarkoidose: ein klinisch orientierter Überblick
Finger R, Rodriguez R, Schönegg R, Kluckert J, Brutsche M. Sarkoidose: ein klinisch orientierter Überblick. Schweizerisches Medizin Forum 2013:265-270.
26.03.2013Sarkoidose: ein klinisch orientierter Überblick
26.03.2013Schweizerisches Medizin Forum 2013:265-270
Finger Rebekka, Rodriguez Regulo, Schönegg René, Kluckert Jörg-Thomas, Brutsche Martin
Analysis of the EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma before Treatment with Gefitinib
Bontognali S, Pless M, Brutsche M, Fischer C, Rochlitz C, Buess M. Analysis of the EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma before Treatment with Gefitinib. Onkologie 2013; 36:161-6.
18.03.2013Analysis of the EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma before Treatment with Gefitinib
18.03.2013Onkologie 2013; 36:161-6
Bontognali Sven, Pless Miklos, Brutsche Martin, Fischer Claude, Rochlitz Christoph, Buess Martin
Determinants of endothelial function in patients with COPD
Clarenbach C, Russi E, Thurnheer R, Puhan M, Rossi V, van Gestel A, Camen G, Sievi N, Senn O, Kohler M. Determinants of endothelial function in patients with COPD. Eur Respir J. 2013; 42:1194-204.
21.02.2013Determinants of endothelial function in patients with COPD
21.02.2013Eur Respir J. 2013; 42:1194-204
Clarenbach Christian F, Russi Erich W, Thurnheer Robert, Puhan Milo A, Rossi Valentina A, van Gestel Arnoldus, Camen Giovanni, Sievi Noriane A, Senn Oliver, Kohler Malcolm
Diagnosis and management of chronic obstructive pulmonary disease: the swiss guidelines: official guidelines of the Swiss Respiratory Society
Russi E, Steurer-Stey C, Rochat T, Quadri F, Nicod L, Kuhn M, Geiser T, Frey M, Fitting J, Eich C, Brutsche M, Karrer W, Stolz D. Diagnosis and management of chronic obstructive pulmonary disease: the swiss guidelines: official guidelines of the Swiss Respiratory Society. Respiration 2013; 85:160-74.
11.02.2013Diagnosis and management of chronic obstructive pulmonary disease: the swiss guidelines: official guidelines of the Swiss Respiratory Society
11.02.2013Respiration 2013; 85:160-74
Russi E W, Steurer-Stey C, Rochat T, Quadri F, Nicod L, Kuhn M, Geiser T, Frey M, Fitting J W, Eich C, Brutsche Martin, Karrer W, Stolz D
Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
Albrich W, Conca A, Schäfer P, Schubert M, De Geest S, Reutlinger B, Irani S, Bürgi U, Huber A, Guglielmetti M, Schild U, Rüegger K, Dusemund F, Schuetz P, Arici B, Litke A, Blum C, Bossart R, Regez K, Müller B. Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial. Eur Respir J. 2013; 42:1064-75.
24.01.2013Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
24.01.2013Eur Respir J. 2013; 42:1064-75
Albrich Werner, Conca Antoinette, Schäfer Petra, Schubert Maria, De Geest Sabina, Reutlinger Barbara, Irani Sarosh, Bürgi Ulrich, Huber Andreas, Guglielmetti Merih, Schild Ursula, Rüegger Kristina, Dusemund Frank, Schuetz Philipp, Arici Birsen, Litke Alexander, Blum Claudine A, Bossart Rita, Regez Katharina, Müller Beat
Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD)
van Gestel A, Kohler M, Clarenbach C. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD). Discov Med 2012; 14:359-68.
01.12.2012Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD)
01.12.2012Discov Med 2012; 14:359-68
van Gestel Arnoldus, Kohler Malcolm, Clarenbach Christian F
Predicting daily physical activity in patients with chronic obstructive pulmonary disease
van Gestel A, Clarenbach C, Stöwhas A, Rossi V, Sievi N, Camen G, Russi E, Kohler M. Predicting daily physical activity in patients with chronic obstructive pulmonary disease. PloS one 2012; 7:e48081.
02.11.2012Predicting daily physical activity in patients with chronic obstructive pulmonary disease
02.11.2012PloS one 2012; 7:e48081
van Gestel Arnoldus, Clarenbach Christian F, Stöwhas Anne C, Rossi Valentina A, Sievi Noriane A, Camen Giovanni, Russi Erich W, Kohler Malcolm
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528
Gautschi O, Stahel R, Carbone D, Na K, Hsu Schmitz S, Bubendorf L, Baty F, Brutsche M, Pless M, Zappa F, Roder J, Grigorieva J, Roder H, Peters S, Crowe S, Dingemans A, Smit E. VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer 2012; 79:59-64.
01.11.2012VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528
01.11.2012Lung Cancer 2012; 79:59-64
Gautschi Oliver, Stahel Rolf, Carbone David, Na Kyung-Jae, Hsu Schmitz Shu-Fang, Bubendorf Lukas, Baty Florent, Brutsche Martin, Pless Miklos, Zappa Francesco, Roder Joanna, Grigorieva Julia, Roder Heinrich, Peters Solange, Crowe Susanne, Dingemans Anne-Marie, Smit Egbert
Outcome of Percutaneous Endoscopic Gastrostomy Tube Insertion in Respiratory Impaired Amyotrophic Lateral Sclerosis Patients Under Non-Invasive Ventilation
Czell D, Bauer M, Binek J, Schoch O, Weber M. Outcome of Percutaneous Endoscopic Gastrostomy Tube Insertion in Respiratory Impaired Amyotrophic Lateral Sclerosis Patients Under Non-Invasive Ventilation. Respir Care 2012
26.10.2012Outcome of Percutaneous Endoscopic Gastrostomy Tube Insertion in Respiratory Impaired Amyotrophic Lateral Sclerosis Patients Under Non-Invasive Ventilation
26.10.2012Respir Care 2012
Czell David, Bauer Matthias, Binek Janek, Schoch Otto, Weber Markus
An uncommon reason for dyspnoea: phrenic paresis secondary to alveolar echinococcosis
Wassmer P, Chronis J, Rüdiger J, Boggian K. An uncommon reason for dyspnoea: phrenic paresis secondary to alveolar echinococcosis. Eur Respir J. 2012; 40:1053-5.
01.10.2012An uncommon reason for dyspnoea: phrenic paresis secondary to alveolar echinococcosis
01.10.2012Eur Respir J. 2012; 40:1053-5
Wassmer Philipp, Chronis Joannis, Rüdiger Jochen, Boggian Katia
Asthma and the regulated retrotransposon transcriptome
Miglino N, Roth M, Baty F, Brutsche M, Tamm M, Borger P. Asthma and the regulated retrotransposon transcriptome. Eur Respir J. 2012; 40:788-90.
01.09.2012Asthma and the regulated retrotransposon transcriptome
01.09.2012Eur Respir J. 2012; 40:788-90
Miglino Nicola, Roth Michael, Baty Florent, Brutsche Martin, Tamm Michael, Borger Pieter
EGFR exon-level biomarkers of the response to bevacizumab-erlotinib in advanced non-squamous non-small cell lung cancer (NSCLC)
Baty F (2012). EGFR exon-level biomarkers of the response to bevacizumab-erlotinib in advanced non-squamous non-small cell lung cancer (NSCLC) - A translational substudy of SAKK 19/05.
23.05.2012EGFR exon-level biomarkers of the response to bevacizumab-erlotinib in advanced non-squamous non-small cell lung cancer (NSCLC)
23.05.2012Conference of the American Thoracic Society
Baty Florent
Infraclavicular sensor site: a new promising site for transcutaneous capnography
Chhajed P, Chaudhari P, Tulasigeri C, Kate A, Kesarwani R, Miedinger D, Leuppi J, Baty F. Infraclavicular sensor site: a new promising site for transcutaneous capnography. Scand J Clin Lab Invest 2012; 72:340-2.
24.03.2012Infraclavicular sensor site: a new promising site for transcutaneous capnography
24.03.2012Scand J Clin Lab Invest 2012; 72:340-2
Chhajed Prashant N, Chaudhari Parag, Tulasigeri Chandrashekhar, Kate Arvind, Kesarwani Rajendra, Miedinger David, Leuppi Joerg, Baty Florent